Clinical trial
Acetazolamide and Statins for the Treatment of Chronic Mountain Sickness in Highlanders: A Randomized Controlled Trial
NCT04251364 is registered in ClinicalTrials.gov with Centre d'Expertise sur l'Altitude EXALT as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acetazolamide and Statins for the Treatment of Chronic Mountain Sickness in Highlanders: A Randomized Controlled Trial
- Lead sponsor
- Centre d'Expertise sur l'Altitude EXALT
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 15, 2020
- Completion date
- December 30, 2021
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypoxia, altitude